These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 3111893)

  • 21. Clinical application of a gonadotropin releasing hormone analog (buserelin) in the treatment of uterine leiomyomas.
    Acar B; Posaci C
    Int J Gynaecol Obstet; 1992 May; 38(1):52-3. PubMed ID: 1348994
    [No Abstract]   [Full Text] [Related]  

  • 22. A case of benign metastasizing leiomyoma treated by surgical castration followed by an aromatase inhibitor, anastrozole.
    Nasu K; Tsuno A; Takai N; Narahara H
    Arch Gynecol Obstet; 2009 Feb; 279(2):255-7. PubMed ID: 18523791
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pulmonary densities following a hysterectomy, caused by benign metastatic leiomyoma].
    Scheer ML; Slebos DJ; Bogchelman DH; Timens W
    Ned Tijdschr Geneeskd; 2008 Sep; 152(37):2027-31. PubMed ID: 18825892
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intravenous leiomyomatosis of the uterus with pulmonary metastases or a case with benign metastasizing leiomyoma?
    Bodner-Adler B; Bartl M; Wagner G
    Anticancer Res; 2009 Feb; 29(2):495-6. PubMed ID: 19331193
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of intranasal luteinizing hormone-releasing hormone agonist in uterine leiomyomas.
    Maheux R; Lemay A; Merat P
    Fertil Steril; 1987 Feb; 47(2):229-33. PubMed ID: 3102282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of uterine fibroids with implants of gonadotropin-releasing hormone agonist: assessment by hysterography.
    Donnez J; Schrurs B; Gillerot S; Sandow J; Clerckx F
    Fertil Steril; 1989 Jun; 51(6):947-50. PubMed ID: 2498131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fourteen-day versus twenty-one-day regimens of intermittent intranasal luteinizing hormone-releasing hormone agonist combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A; Faure N
    J Clin Endocrinol Metab; 1986 Dec; 63(6):1379-85. PubMed ID: 2946711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ovarian sonographic findings during intermittent intranasal luteinizing hormone-releasing hormone agonist sequentially combined with an oral progestogen as antiovulatory contraceptive approach.
    Lemay A; Faure N; Bastide A
    Fertil Steril; 1987 Jan; 47(1):60-6. PubMed ID: 2947818
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Shrinkage of uterine leiomyomas after intranasal administration of a LHRH agonist].
    Uemura T; Kimura A; Shirasu K; Minaguchi H
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Mar; 41(3):365-8. PubMed ID: 2499643
    [No Abstract]   [Full Text] [Related]  

  • 30. Intravascular leiomyomatosis and benign metastasizing leiomyoma: an unusual case.
    Arif S; Ganesan R; Spooner D
    Int J Gynecol Cancer; 2006; 16(3):1448-50. PubMed ID: 16803546
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A; Faure N; Labrie F; Fazekas AT
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [GnRH-analogs in the therapy of uterine myomatosis].
    Wieacker P; Geisthövel F; Adelberger V; Breckwoldt M
    Ther Umsch; 1990 Dec; 47(12):951-7. PubMed ID: 2151405
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonist.
    Lemay A; Quesnel G
    Fertil Steril; 1982 Sep; 38(3):376-9. PubMed ID: 6214431
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical predictors for buserelin acetate treatment of uterine fibroids: a prospective study of 40 women.
    Vollenhoven BJ; Shekleton P; McDonald J; Healy DL
    Fertil Steril; 1990 Dec; 54(6):1032-8. PubMed ID: 2123160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Preoperative reduction of uterine leiomyoma by the GnRH-analog goserelin (zoladex)].
    Hackenberg R; Gesenhues T; Deichert U; Duda V; Sturm G; Schulz KD
    Geburtshilfe Frauenheilkd; 1990 Feb; 50(2):136-9. PubMed ID: 2138580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The mechanisms of antitumor effects of luteinizing hormone-releasing hormone agonist (buserelin) in 7, 12-dimethylbenz(a)anthracene-induced rat mammary cancer.
    Koibuchi Y; Sugamata N; Iino Y; Yokoe T; Andoh T; Maemura M; Takei H; Horiguchi J; Matsumoto H; Morishita Y
    Int J Mol Med; 1999 Aug; 4(2):145-8. PubMed ID: 10402480
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pulmonary benign metastasizing leiomyoma associated with intravenous leiomyomatosis of the uterus: clinical behavior and genomic changes supporting a transportation theory.
    Lee HJ; Choi J; Kim KR
    Int J Gynecol Pathol; 2008 Jul; 27(3):340-5. PubMed ID: 18580311
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pulmonary benign metastasizing leiomyoma: a report of 2 cases with different outcomes.
    Benetti-Pinto CL; Soares PM; Petta CA; De Angelo-Andrade LA
    J Reprod Med; 2006 Sep; 51(9):715-8. PubMed ID: 17039701
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Case of concurrent benign metastasizing leiomyoma in the lung and retroperitoneum, with a focus on its etiology.
    Tohya T; Tajima T; Takeshita Y; Ito K; Kuriwaki K; Katabuchi H
    J Obstet Gynaecol Res; 2014 Aug; 40(8):2010-3. PubMed ID: 25131768
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Benign metastasizing pulmonary leiomyoma: description of a case and review of the literature].
    Sentinelli S; Covello R; Benevolo M; Licci S; Perrone Donnorso R
    Pathologica; 2002 Oct; 94(5):253-6. PubMed ID: 12417973
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.